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Low-density lipoprotein receptor-related protein-1 (LRP-1) is a multifunctional
matricellular receptor composed of a large ligand-binding subunit (515-kDa α-chain)
associated with a short trans-membrane subunit (85-kDa β-chain). LRP-1, which
exhibits both endocytosis and cell signaling properties, plays a key role in tumor
invasion by regulating the activity of proteinases such as matrix metalloproteinases
(MMPs). LRP-1 is shed at the cell surface by proteinases such as membrane-type 1
MMP (MT1-MMP) and a disintegrin and metalloproteinase-12 (ADAM-12). Here, we
show by using biophysical, biochemical, and cellular imaging approaches that efficient
extraction of cell cholesterol and increased LRP-1 shedding occur in MDA-MB-231
breast cancer cells but not in MDA-MB-435 cells. Our data show that cholesterol is
differently distributed in both cell lines; predominantly intracellularly for MDA-MB-231
cells and at the plasma membrane for MDA-MB-435 cells. This study highlights the
relationship between the rate and cellular distribution of cholesterol and its impact on
LRP-1 shedding modulation. Altogether, our data strongly suggest that the increase
of LRP-1 shedding upon cholesterol depletion induces a higher accessibility of the
sheddase substrate, i.e., LRP-1, at the cell surface rather than an increase of expression
of the enzyme.
Keywords: LRP-1, low-density lipoprotein receptor-related protein-1, ectodomain, cholesterol, shedding, Raman
microspectroscopy
INTRODUCTION
The low-density lipoprotein receptor-related protein-1 (LRP-1) is a large heterodimeric receptor
composed of an heavy extracellular chain, the 515-kDa α-chain, non-covalently associated with a
light transmembrane chain, the 85-kDa β-chain (Emonard et al., 2014). The extracellular α-chain
exhibits four cystein-rich complement-type repeats which bind more than 40 ligands, including
proteinases and proteinase:inhibitor complexes (Etique et al., 2013). Motifs of the intracellular
part of the β-chain activate endocytosis and signaling pathways (Lillis et al., 2005), which drive
numerous biological functions and play a key role in the development of many pathological
disorders (Lillis et al., 2008; Van Gool et al., 2015). LRP-1 invalidation in mice is lethal at early stage
of embryogenesis (Herz et al., 1992). We previously demonstrated that LRP-1 promotes invasion
of malignant cells by modulating focal complex composition (Dedieu et al., 2008).
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Low-density lipoprotein receptor-related protein-1 is broadly
expressed in multiple cell types such as mesenchymal and
epithelial cells (Emonard et al., 2014). Its expression is regulated
by hormones and growth factors that induce diﬀerent responses
depending on cell types. Cell surface LRP-1 is cleaved by shedding
to generate soluble LRP-1 ectodomain composed of the entire
extracellular α-chain linked to the extracellular part of the
β-chain which was ﬁrst discovered in plasma (Quinn et al.,
1997). The ﬁrst LRP-1 sheddase was characterized in human
choriocarcinoma BeWo cells as a metalloproteinase (Quinn
et al., 1999). More recently our group identiﬁed a disintegrin
and metalloproteinase-12 (ADAM-12) and membrane-type 1
matrix metalloproteinase (MT1-MMP; Selvais et al., 2009, 2011).
Several proteolytic enzymes belonging to other proteinases
families have also been identiﬁed (for a review, Emonard et al.,
2014).
Shedding is a closely regulated process that controls most
of types I and II transmembrane proteins levels at cell surface
(Hartmann et al., 2013). Cellular cholesterol depletion stimulates
shedding of the interleukin-6 receptor (Matthews et al., 2003) and
CD30 antigen (von Tresckow et al., 2004). By comparing two
cell lines exhibiting diﬀerent levels of cholesterol (conventional
human ﬁbrosarcoma HT1080 cells and an epithelioid variant
with a twofold higher cell cholesterol content), we previously
showed that low cell cholesterol level promotes LRP-1 shedding
(Selvais et al., 2011).
Cholesterol is widely expressed at cell surface of mammalian
cells but can also be located in the cytosolic compartment
where it could play a role in transmembrane protein traﬃcking
(Mukherjee et al., 1998). In the present study, we evaluated the
eﬃciency of LRP-1 shedding process in cell lines expressing either
cholesterol at plasma membrane or in cytosolic compartment
(Nieva et al., 2012). We demonstrated by using diﬀerent
imaging approaches, that eﬃcient extraction of cholesterol
and increased LRP-1 shedding occur predominantly in cells
exhibiting cholesterol at cell surface.
MATERIALS AND METHODS
Reagents and Antibodies
Dulbecco’s modiﬁed Eagle medium (DMEM) and other
cell culture reagents were purchased from Thermo Fisher
Scientiﬁc (Illkirch, France). Fetal calf serum (FCS) was from
Dutscher (Brumath, France). Filipin, methyl-β-cyclodextrin
(MβCD) and other chemicals were from Sigma-Aldrich
(Saint-Quentin Fallavier, France). Phosphate-buﬀered saline
(PBS)-B (131 mM NaCl, 5.1 mM Na2HPO4, and 1.5 mM
KH2PO4) was from bioMérieux (Craponne, France). Anti-LRP-1
α-chain (mouse, clone 8G1) was from Calbiochem (Merck
Biosciences, distributed by VWR International, Strasbourg,
France). Goat polyclonal antibodies directed against β-actin
were from Abcam (Paris, France). Horseradish peroxidase
(HRP)-conjugated anti-mouse antibodies were from Cell
Signaling Technology (distributed by Ozyme, Montigny-
Le-Bretonneux, France) and HRP-anti-goat antibodies from
Sigma-Aldrich.
Cell Culture
Human breast cancer cell lines MDA-MB-231 and MDA-MB-
435 were obtained from the American Type Culture Collection.
MDA-MB-231 and MDA-MB-435 cells were cultured in DMEM
containing 1 and 4.5 g/l glucose, respectively. Culture media
were supplemented with 10% FCS, 100 units/ml penicillin and
10 mg/ml streptomycin. For cell imaging, FCS was depleted in
lipoproteins following a procedure adapted from the Havel et al.
(1955). Cells were grown at 37◦C in a humid atmosphere (5%
CO2 and 95% air). As cellular cholesterol content depends, at least
in part, on cellular conﬂuency state (Takahashi et al., 2007), all
experiments were carried out at similar cell densities.
MβCD Treatment and Cholesterol Assay
Thewater-soluble MβCD forms soluble inclusion complexes with
cholesterol, enhancing thus its solubility in aqueous solution
(Pitha et al., 1988) and is classically used to extract cholesterol
from cultured cells. In the present study, cells were treated
with MβCD (0–20 mM) in FCS-free medium for 30 min at
37◦C. Cells were then harvested in reaction buﬀer (0.1 M
potassium phosphate, pH 7.4, 50 mM NaCl, 5 mM cholic acid,
and 0.1% Triton X-100) and sonicated. Cholesterol content was
quantiﬁed using the Amplex Red cholesterol assay kit (Invitrogen
distributed by Thermo Fisher Scientiﬁc), as recommended by
the manufacturer. Reactions proceeded for 20 min at 37◦C.
Alternatively, after treatment with MβCD cells were washed with
PBS and further incubated in FCS-free medium for 24 h. Twenty
four-hour conditioned media were concentrated and shedding of
LRP-1 was analyzed by western blotting.
Raman Microspectroscopy Analysis
Cells (3 × 104) were seeded in 6-well plates containing CaF2
substrates (Crystan, Ltd., Dorset, UK), and 48 h later cells
were ﬁxed with 4% cold paraformaldehyde (PFA) for 30 min at
room temperature. After ﬁxing, cells were washed three times
with PBS and water, before drying to be analyzed with Raman
spectroscopy.
Raman spectra were acquired from each sample using
a LabRAM Raman spectrometer (Jobin Yvon, Horiba, Lille
France). The setup contained a laser diode at 660 nm supplying
an excitation beam of 25 mW at the sample. The laser beam
was focused onto the sample using a Leica HCX PL FluoTar
x100 objective (NA = 0.75). The same objective collected the
light scattered from the sample. An edge ﬁlter permitted to reject
the laser reﬂection and the Rayleigh scattering. A grating of
1200 g/mm ensured the dispersion of the Raman Stokes signal
with a spectral resolution of 4 cm−1. The intensity of the Raman
vibrations was measured using a deep depletion charge-coupled
device (CCD) detector. The spectra were collected on a total
spectral range from 400 to 4000 cm−1, with an acquisition time
of 40 s per spectrum. For each cell, a number of ﬁve spectra
were collected at the level of the cytoplasm. Raman data were
then baseline-corrected using linear segments, slightly smoothed
(three points averaging) and normalized on the basis of the
total integrated intensity. The ﬁve spectra recorded on each cell
were averaged. Up to this point, the acquisition and processing
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of the data were performed using Labspec 5 software (Horiba
Jobin Yvon, Lille France). Then, Raman data were submitted
to statistical multivariate processing corresponding to principal
component analysis (PCA). PCA operated via a home-made
interface using Matlab Toolbox (MathWorks R©). Mean-centered
data were used for PCA.
Cholesterol Staining and Cell Imaging
Cells (5 × 104) were seeded onto gelatin-coated glass slides and
cultured in media containing lipoproteins-depleted FCS for 24 h
at 37◦C. Then, cells were treated or not with MβCD and ﬁxed
in 3% paraformaldehyde for 60 min at room temperature. After
three washes in PBS, cells were incubated in glycine (1.5 mg/ml
in PBS-B) for 10 min and then stained with ﬁlipin (0.05 mg/ml
in PBS-B) for 2 h at room temperature. Filipin-stained cell
preparations were analyzed using a Zeiss LSM 710 confocal
laser scanning microscope with the 63x oil-immersion objective
and Zen operating system (Zeiss, Heidelberg, Germany). All
acquisitions were performed with UPlan x 63, 1.4 numerical
aperture objective by exciting ﬁlipin with a chameleon infrared
laser tuned at 740 nm. Emitted ﬂuorescence was detected through
the appropriate ﬁlter and twenty images were captured with a
0.25-μm z-step. DIC images were acquired simultaneously with
the reﬂected light images using a TPMT module. Images were
treated with AmiraTM software (v6.0.1, FEI visualization Sciences
Group, Merignac, France) and projection through each z-stack
was merged with DIC images.
RNA Isolation, RT-PCR, and
Real-Time-PCR
Total RNAs were isolated and puriﬁed with Extract-All
kit (Eurobio Laboratories, Courtaboeuf, France). Reverse
transcription (RT) and real-time PCR were performed with
Verso SYBR 2-Step QRT Rox kit (AB-4113/A) and Absolute
QPCR SYBR Green Rox (AB-1162/B), respectively (Thermo
Fisher Scientiﬁc). Quantitative PCR was carried out on a
Chromo4 Real-Time Detector (Bio-Rad Laboratories, Marne-la-
Vallée, France). Data were normalized to ribosomal proteins L32
(RPL32) and S18 (RS18) or to β-actin. Primers for LRP-1 (Dedieu
et al., 2008) and β-actin (Langlois et al., 2010) were previously
described. Primers were synthesized as follows: for MT1-MMP,
AACCAAGTGATGGATGGATACC and CTCCTTAATGTGCT
TGGGGTAG; for transmembrane form of ADAM-12, ADAM-
12L, GGGCTGTAGCTGTCAAATGGand CTGACTTCCGGCA
GGTTAAA; for RPL32, CATTGGTTATGGAAGCAACAAA
and TTCTTGGAGGAAACATTGTGAG; for RS18, GCAGAAT
CCACGCCAGTACAA and GCCAGTGGTCTTGGTGTGCT
(Eurogentec France, Angers, France). Results shown are
representative of three independent experiments.
Sample Preparation and Western Blot
Analysis
Cells treated or not with MβCD were then washed with PBS and
further incubated with FCS-free medium for 24 h. Twenty four-
hour-conditioned media were cleared by centrifugation (1,000 g
at 4◦C for 10 min) and concentrated 50-fold with Vivaspin
centrifugal concentrators (Sartorius Stedim Biotech, distributed
by Dutscher) following manufacturer’s recommendations. Cells
were scraped in ice-cold lysis buﬀer (10 mM CHAPS, 20 mM
HEPES (pH 7.4), 150 mM NaCl, 2 mM CaCl2, 1 mM
phenylmethylsulfonylﬂuroide supplemented with proteinase
inhibitor cocktail from Sigma-Aldrich). After sonication, the
remaining pellet was discarded by centrifugation (10,000 g at 4◦C
for 10 min).
Western blotting was performed as previously described
(Selvais et al., 2011) using 5% polyacrylamide gel for LRP-
1 515 kDa α-chain and 10% polyacrylamide gel for β-actin.
Primary antibodies were used at 1/4000 for LRP-1 α-chain and
1/1000 for β-actin. Samples were normalized with respect to cell
protein amount, which was determined using BC assay protein
quantitation kit (Thermo Scientiﬁc, distributed by Interchim,
Montluçon, France). Each lane was loaded with cell lysates
equivalent of 40 μg protein, or corresponding amounts of
conditioned medium. Immunoreactive bands were revealed
using the ECL chemiluminescence kit (Amersham Biosciences,
distributed by Dutscher), acquired using the Odyssey R© Fc Dual-
Mode LI-CORE Imaging System (Biosciences Biotechnology,
distributed by Eurobio Laboratories) and quantiﬁed using
ImageJ software. β-actin antibodies were used for normalization.
Immunoblots presented are representative of at least three
independent experiments.
Statistical Analysis
Data were analyzed using unpaired two-tailed Student’s t-test.
Diﬀerences were considered signiﬁcant for P < 0.05. Values are
reported as mean ± SD.
RESULTS
We previously reported in the human ﬁbrosarcoma HT1080
cell line the correlation between cell cholesterol amount and
eﬃciency of LRP-1 shedding (Selvais et al., 2011). In the present
study we investigated the possible role of cholesterol distribution
by using two diﬀerent breast cancer cell lines MDA-MB-231 and
MDA-MB-435 cells, one expressing cholesterol in the cytosol and
the other at the plasma membrane (Nieva et al., 2012).
MDA-MB-231 and MDA-MB-435 Breast
Cancer Cells Exhibit Different Lipid
Phenotypes
We ﬁrst explored the lipid phenotype of MDA-MB-231 and
MDA-MB-435 cells by Raman microspectroscopy. Spectra
collected on the cytoplasmic compartment of the two cell lines
were processed by PCA, an exploratory unsupervised method of
multivariate data processing. PCA is commonly used to explore
the intra- and inter-group variabilities based on the Raman
signals of the cells (Poplineau et al., 2011). A distinction between
the two cell types is clearly visible on the score plot constructed
on the two ﬁrst components (Figure 1A). The distinction relies
mainly on the ﬁrst principal component (PC1) that exhibits
signals assigned to lipid vibrations (Figure 1B). Indeed, the
spectral zones grayed on the display of the ﬁrst component,
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FIGURE 1 | Cytoplasmic lipid profiling of MDA-MB-231 and
MDA-MB-435 cells by Raman analysis. (A) Score plot resulting of the PCA
processing of Raman spectra collected on MDA-MB-231 (red circles) and
MDA-MB-435 (blue circles) cells. The scores were projected on the two first
principal components. (B) Display of the two first principal components. The
Raman features comprising the main variability of the spectral data, were
highlighted by the grayed underlining.
centered at 1450 and 2850 cm−1, are assigned to bending and
stretching vibrations of lipid CH2 and CH3 groups respectively.
This analysis reﬂects that the lipid contribution of the cytoplasm
as probed by Raman spectroscopy allows distinguishing MDA-
MB-231 and MDA-MB-435 cells. The same Raman features
are also recovered on the second principal component (PC2),
reﬂecting their involvement in the intra-group variability of these
cellular samples.
Efficiency of Cholesterol Depletion
Depends on its Cellular Distribution
We next investigated using biochemical and cellular imaging
analyses whether the biophysical analysis ﬁndings showing
diﬀerent cytoplasmic lipids-based discrimination between MDA-
MB-231 and MDA-MB-435 cells was conﬁrmed for cholesterol.
Similar cholesterol content was quantiﬁed in untreated MDA-
MB-231 and -435 cells, with 11.1 ± 2.9 μg cholesterol/mg
cell protein and 10.3 ± 2.9 μg cholesterol/mg cell protein,
respectively. MDA-MB-231 and -435 cells were then treated
with increasing concentrations of MβCD (5, 10, and 20 mM)
FIGURE 2 | Differential efficiency of MβCD for depleting cholesterol.
MDA-MB-231 (A) and MDA-MB-435 (B) breast cancer cells were treated as
described under Section “Materials and Methods” with increasing
concentrations of MβCD and cellular cholesterol content was then measured.
Values expressed as μg cholesterol/mg cell protein are mean ± SD (n = 6 for
each cell line). NS, not significant, ∗P < 0.05; Student’s t-test.
to extract cholesterol and the eﬀect on cell cholesterol depletion
was measured (Figure 2). Five millimolar MβCD had no eﬀect
on cell cholesterol amount in the two cell lines. In MDA-MB-
231 cells a depletion peak of cell cholesterol was observed at
10 mM of MβCD (Figure 2A). In contrast, in MDA-MB-435
cells cell cholesterol amount did not vary upon MβCD treatment
(Figure 2B). Filipin-labeled cells revealed that cholesterol was
predominantly distributed in cytosol for MDA-MB-231 cells
(Figure 3A, white arrow) and in plasma membrane inMDA-MB-
435 cells (Figure 3C, red arrow). Interestingly, eﬃcient extraction
of cholesterol uponMβCD treatment was observed inMDA-MB-
231 cells (Figure 3B) but not in MDA-MB-435 cells (Figure 3D).
Decrease of Cell Cholesterol Content
Potentiates Shedding of LRP-1 without
Affecting the Expression of LRP-1,
MT1-MMP, and ADAM-12
We then investigated if modulation of cell cholesterol amount by
MβCD treatment had an impact on LRP-1 shedding process in
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FIGURE 3 | MβCD exhibits different effects on cholesterol depletion in
MDA-MB-231 and MDA-MB-435 breast cancer cell lines. MDA-MB-231
(A,B) and MDA-MB-435 (C,D) cells were treated as described under Section
“Materials and Methods” with vehicle alone (A,C) or 10 mM MβCD (B,D).
Cells were fixed in 3% PFA and treated with filipin (50 μg/mL) for 2 h at room
temperature. Projection of each z-stack acquired through confocal
microscopy images was merged with DIC images. Filipin labels free
cholesterol present in the membranes (red arrow) and in the cytosol (white
arrow). Scale bar: 10 μm, n, nucleus.
MDA-MB-231 and -435 cells (Figure 4), as previously reported
for the human ﬁbrosarcoma HT1080 cells (Selvais et al., 2011).
In the absence of MβCD treatment, LRP-1 expression is similar
in MDA-MB-231 and -435 cells (Figures 4A,B). LRP-1 levels are
also comparable in CHAPS extracts fromMDA-MB-231 and -435
cells as well as in their respective conditioned media (Figure 4C).
By using MβCD at 10 mM, a concentration that eﬃciently
depleted MDA-MB-231 cells in cholesterol (Figure 2A), we
observed a large decrease of LRP-1 in the CHAPS extracts of
MDA-MB-231 cells that was accompanied by a twofold increase
of soluble LRP-1 in conditioned media (Figures 4C,D). In
contrast MβCD treatment, which did not modify cholesterol
amount in MDA-MB-435 cells (Figure 2B), had no eﬀect on
LRP-1 shedding in these cells (Figures 4C,D).
To exclude that diﬀerences of LRP-1 shedding levels that
we observed between the two breast cancer cell lines could be
attributed to modulations of LRP-1, MT1-MMP and/or ADAM-
12, its main sheddases (Selvais et al., 2011), we tested the eﬀect
of MβCD treatment on the expression of these three molecules.
Neither LRP-1 mRNA (Figure 5A) nor MT1-MMP mRNA
(Figure 5B) and ADAM-12 (Figure 5C) levels were aﬀected by
10 mMMβCD treatment.
DISCUSSION
In the present study we investigated the relationship between
cholesterol cell distribution and LRP-1 shedding eﬃciency. For
this purpose, we used MDA-MB-231 and MDA-MB-435 cells,
FIGURE 4 | Depletion of cellular cholesterol by MβCD increases
shedding of the LRP-1 ectodomain. MDA-MB-231 and MDA-MB-435
cells were treated as described under Section “Materials and Methods” with
vehicle alone or 10 mM MβCD. Basal level expression of LRP-1 was
measured by quantitative real-time PCR. Data were normalized to ribosomal
proteins RPL32 (A) and RS18 (B). Western blotting of LRP-1 α-chain and
β-actin was performed from cell lysates, and blotting of LRP-1 α-chain in
corresponding amounts of 24-h conditioned medium. Data are from a
representative experiment (C). LRP-1 ectodomain shedding was quantified on
Western blots of LRP-1 α-chain released in the concentrated conditioned
medium (D). NS, not significant, ∗P < 0.05; Student’s t-test.
two cancer cell lines recently described for exhibiting diﬀerent
patterns of cholesterol localization, respectively in the cytoplasm
and in the plasma membrane (Nieva et al., 2012). Treatment by
MβCDdecreased amount of cholesterol that was mainly localized
in cytoplasm and stimulated removal of cell-surface LRP-1. In
contrast, such a treatment had no eﬀect on cholesterol levels
predominantly distributed at the plasma membrane and on the
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FIGURE 5 | Depletion of cellular cholesterol by MβCD has no effect on
the expression of LRP-1 or its sheddases MT1-MMP and ADAM-12.
Quantitative real-time PCR of LRP-1 (A), MT1-MMP (B) and ADAM-12 (C)
mRNA levels. After normalization to β-actin mRNA amounts (Langlois et al.,
2010), data were presented as a percentage of untreated cells. Values are
mean ± SD (n = 3 for each cell line). NS, not significant; Student’s t-test.
release of the LRP-1 ectodomain. These discrepancies are not
related to modiﬁed expression of LRP-1 and/or of its sheddases,
MT1-MMP and ADAM-12. Altogether, these data suggested that
cell distribution of cholesterol aﬀects the shedding of LRP-1 from
the cell surface.
The lipid proﬁling of MDA-MB-231 and MDA-MB-
435 breast cancer cells was ﬁrst investigated using Raman
microspectroscopy. Raman microspectroscopy was performed
on single living cells. The non-destructive and label free
spectral analysis permitted to highlight the lipid contribution
of the cytoplasmic compartment as a distinctive biochemical
characteristic between the two cell types. The discriminant
potential of this biophotonic approach was shown by a standard
PCA. This unsupervised processing revealed also a marked
intra-group variability as visible on the score plot of Figure 1.
The origin of this variability could be investigated by carrying
out spectral imaging at the cellular level (Abramczyk et al.,
2015). Innovative devices, based on stimulate Raman scattering,
have been recently proven to map the cellular lipid distribution
in video-rate imaging (Ramachandran et al., 2015). Raman
microspectroscopy allowed us to partially discriminate the two
cell lines on the basis of their cytoplasmic spectral signature
of lipids, including cholesterol as previously described (Nieva
et al., 2012). Recent data obtained by ﬂuorescence microscopy
study after ﬁlipin staining indicated that cholesterol was mainly
concentrated in cytoplasm of MDA-MB-231 cells while it was
mostly distributed in plasma membrane of MDA-MB-435
cells (Nieva et al., 2012). In the present study, the observation
of ﬁlipin-stained MDA-MB-231 and MDA-MB-435 cells by
confocal microscope conﬁrmed such ﬁndings.
The eﬃcient depletion of cytoplasmic cholesterol in MDA-
MB-231 cells after treatment with MβCD indicates that
such a compound can pass through plasma membrane for
extracting cholesterol from membranes of cytosolic vesicles,
as previously reported for removal of lysosomal cholesterol
in skin ﬁbroblasts (Swaroop et al., 2012). Unability of MβCD
to extract cholesterol mainly distributed in plasma membrane
of MDA-MB-435 cells (Figures 2 and 3) is rather surprising.
MβCD treatment has indeed been often associated with lipid
raft disintegration (Zimina et al., 2005). The lipid rafts result
of the interaction between cholesterol with sphingolipids in
the outer exoplasmic leaﬂet of the lipid bilayer of cellular
membranes. Cholesterol also interacts with phospholipids in
the inner cytoplasmic leaﬂet of the lipid bilayer. Lipid rafts
are considered to be present as a liquid-ordered phase while
phospholipid-rich domains are in a disordered state (Simons
and Ehehalt, 2002). Giant plasma-membrane vesicles represent
a valuable physiological tool to investigate lipid phase separation
(Baumgart et al., 2007). Using this model, Levental et al. (2009)
demonstrated a cholesterol dependence of phase separation
in complex membranes at physiological conditions. Moreover,
using the same experimental model Sanchez et al. (2011)
demonstrated that MβCD preferentially removed cholesterol
from a liquid disordered phase. A computational microscopy
study recently conﬁrmed that cholesterol was preferentially
extracted from the disordered regions compared to liquid-
ordered domains of lipid model membranes (López et al., 2013).
Altogether, these data suggest that MβCD-resistant cholesterol
in membranes of the MDA-MB-435 cells reﬂects their richness
in lipid rafts. This will be evaluated in a future experiment by
atomic force microscopy, as recently proposed (Cremona et al.,
2015).
The increase of transmembrane receptor shedding was often
related to decrease of cell cholesterol amount, possibly by
disintegration of lipid rafts and dynamic interactions of the
sheddase and its target (Matthews et al., 2003; von Tresckow
et al., 2004; Zimina et al., 2005). We showed similar correlation
of increase of LRP-1 shedding by MT1-MMP and cell cholesterol
decrease upon MβCD treatment in HT1080 cells (Selvais
et al., 2011). Interestingly, our present study highlights a
relationship between cholesterol cell distribution and LRP-
1 shedding eﬃciency. Fluorescence imaging in living CHO
cells clearly evidenced that intracellular cholesterol is mainly
distributed in the endocytic recycling compartment and the
trans-Golgi network (Mukherjee et al., 1998). However, the
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multiplicity of cholesterol transport systems makes diﬃcult
the establishment of speciﬁc traﬃcking route (Chang et al.,
2006). Previous studies demonstrate that cholesterol intracellular
traﬃcking and distribution, rather than total cholesterol levels,
are regulatory factors in the β-amyloid precursor protein
processing (Marzolo and Bu, 2009). Malnar et al. (2012)
proposed that cholesterol regulates the β-amyloid precursor
protein processing by modulating APP expression at the
cell surface. To our knowledge, no relationship between
intracellular cholesterol distribution and LRP-1 localization has
been proposed so far.
CONCLUSION
Our data suggest that intracellular cholesterol depletion may
increase intracellular traﬃcking to cell surface of newly
synthesized LRP-1 and/or recycled LRP-1 after endocytosis
process. Consequently, enhancement of LRP-1 shedding upon
cholesterol depletion should reﬂect a higher disponibility
of the sheddase substrate, i.e., LRP-1, at the cell surface.
However, the question whether intracellular cholesterol
depletion has an impact on LRP-1 localization remains to be
elucidated.
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